Andrew Kenneth William Powell

Insider Reports History

Entity
Individual
Location
C/O Collagenex Pharmaceuticals, Inc., 41 University Drive, Newtown, PA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Kenneth William Powell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LANDEC CORP \CA\ Director Common Stock 27.5K $286K $10.42 Jun 4, 2022 Direct
Aclaris Therapeutics, Inc. Director Common Stock 33.5K $42.2K $1.26 Jun 1, 2024 Direct
Aclaris Therapeutics, Inc. Director Restricted Stock Units 0 $0 $1.26 Jun 1, 2024 Direct
Silverback Therapeutics, Inc. Director Stock Option (right to buy) 18K Jun 10, 2022 Direct
Aclaris Therapeutics, Inc. Director Stock Option (Right to Buy) 15.8K Jun 1, 2023 Direct
LANDEC CORP \CA\ Director Restricted Stock Unit 0 $7.00 Jun 4, 2022 Direct

Insider Reports Filed by Andrew Kenneth William Powell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRS Aclaris Therapeutics, Inc. Jun 1, 2024 2 $0 4 Jun 4, 2024 Director
ACRS Aclaris Therapeutics, Inc. Mar 1, 2024 2 $18K 4 Mar 5, 2024 Director
ACRS Aclaris Therapeutics, Inc. Jun 1, 2023 4 $0 4 Jun 5, 2023 Director
ACRS Aclaris Therapeutics, Inc. Nov 8, 2022 1 $0 4 Jan 20, 2023 Director
SPRY Silverback Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
LFCR LANDEC CORP \CA\ Jun 4, 2022 2 $0 4 Jun 7, 2022 Director
ACRS Aclaris Therapeutics, Inc. Jun 2, 2022 5 $0 4 Jun 6, 2022 Director
LFCR LANDEC CORP \CA\ May 31, 2022 1 $0 4 Jun 2, 2022 Director
ACRS Aclaris Therapeutics, Inc. Nov 23, 2021 1 $0 4 Dec 3, 2021 Director
SPRY Silverback Therapeutics, Inc. Jun 4, 2021 1 $0 4 Sep 21, 2021 Director
LFCR LANDEC CORP \CA\ Jun 4, 2021 1 $0 4 Jun 8, 2021 Director
ACRS Aclaris Therapeutics, Inc. Jun 3, 2021 2 $0 4 Jun 4, 2021 Director
LFCR LANDEC CORP \CA\ Jun 1, 2021 2 $0 4 Jun 3, 2021 Director